Literature DB >> 15128690

The incidence and characteristics of end-of-life decisions by GPs in Belgium.

Johan Bilsen1, Robert Vander Stichele, Freddy Mortier, Jan Bernheim, Luc Deliens.   

Abstract

BACKGROUND: Medical end-of-life decisions (ELDs) have been discussed for several years in different countries, but little is known about the involvement of GPs in these ELDs.
OBJECTIVES: The aim of the present study was to establish the incidence and characteristics of ELDs by GPs.
METHOD: We selected 3999 deaths, a 20% random sample of all registered deaths during the first 4 months of 1998 in Flanders, Belgium, and mailed anonymous questionnaires to the attesting physicians. Here we focus exclusively on the 1647 deaths certified by GPs.
RESULTS: The GPs returned 1067 questionnaires (response rate of 64.8%). At least one ELD was made in 39.5% [95% confidence interval (CI) 37.8-41.2] of all primary care deaths. The incidence of euthanasia (including physician-assisted suicide) was 1.5% (95% CI 0.9-2.3) (incidence higher among more educated patients and at home), of administration of lethal drugs without the patient's explicit request 3.8% (95% CI 2.9-5.0) (higher among cancer patients), of alleviation of pain and symptoms with possibly life-shortening effect 18.6% (95% CI 17.0-20.2) (higher among cancer patients and married patients) and of non-treatment decisions 15.6% (95% CI 14.2-17.2) (higher among cancer patients and in nursing homes). The decision was not discussed with the patient in three out of four of the ELDs. A colleague was consulted in one in four ELD cases.
CONCLUSION: ELDs are common in general practice in Flanders, Belgium, despite the restrictive law concerning euthanasia at the time of this study. The incidence of these ELDs varies with cause and place of death, the patient's education and the GP's religion and age. Requirements of prudent practice regarding ELDs are rather poorly met by GPs. Further international research and debate is needed to highlight the GPs' important role in end-of-life care.

Entities:  

Keywords:  Death and Euthanasia; Empirical Approach

Mesh:

Year:  2004        PMID: 15128690     DOI: 10.1093/fampra/cmh312

Source DB:  PubMed          Journal:  Fam Pract        ISSN: 0263-2136            Impact factor:   2.267


  6 in total

Review 1.  [Euthanasia in patients with cancer and the continuous-care providers].

Authors:  Carlos Camps Herrero; Joaquín Gavilá Gregori; Javier Garde Noguera; Cristina Caballero Díaz; Vega Iranzo González-Cruz; Asunción Juárez Marroquí; Maria José Safont Aguilera; Ana Blasco Cordellat; Alfonso Berrocal Jaime; Maria Godes Sanz de Bremond
Journal:  Clin Transl Oncol       Date:  2005-08       Impact factor: 3.405

2.  Physician reports of medication use with explicit intention of hastening the end of life in the absence of explicit patient request in general practice in Belgium.

Authors:  Koen Meeussen; Lieve Van den Block; Nathalie Bossuyt; Michael Echteld; Johan Bilsen; Luc Deliens
Journal:  BMC Public Health       Date:  2010-04-09       Impact factor: 3.295

3.  End-of-life decision-making in Belgium, Denmark, Sweden and Switzerland: does place of death make a difference?

Authors:  Joachim Cohen; Johan Bilsen; Susanne Fischer; Rurik Löfmark; Michael Norup; Agnes van der Heide; Guido Miccinesi; Luc Deliens
Journal:  J Epidemiol Community Health       Date:  2007-12       Impact factor: 3.710

4.  Physician-related determinants of medical end-of-life decisions - A mortality follow-back study in Switzerland.

Authors:  Matthias Bopp; Yolanda W H Penders; Samia A Hurst; Georg Bosshard; Milo A Puhan
Journal:  PLoS One       Date:  2018-09-20       Impact factor: 3.240

5.  Euthanasia and other end-of-life decisions: a mortality follow-back study in Belgium.

Authors:  Lieve Van den Block; Reginald Deschepper; Johan Bilsen; Nathalie Bossuyt; Viviane Van Casteren; Luc Deliens
Journal:  BMC Public Health       Date:  2009-03-09       Impact factor: 3.295

6.  A post-mortem survey on end-of-life decisions using a representative sample of death certificates in Flanders, Belgium: research protocol.

Authors:  Kenneth Chambaere; Johan Bilsen; Joachim Cohen; Geert Pousset; Bregje Onwuteaka-Philipsen; Freddy Mortier; Luc Deliens
Journal:  BMC Public Health       Date:  2008-08-27       Impact factor: 3.295

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.